JC Jaen

Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose

T. Schall, S. Miao, J. Jaén, 2011, Clinical pharmacology and therapeutics.